Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
BioMarin Pharmaceutical Inc banner

BioMarin Pharmaceutical Inc
SWB:BM8

Watchlist Manager
BioMarin Pharmaceutical Inc Logo
BioMarin Pharmaceutical Inc
SWB:BM8
Watchlist
Price: 52.86 EUR 1.89%
Market Cap: €10B
Write Note Create Alert Ask AI

Intrinsic Value

The intrinsic value for BioMarin Pharmaceutical Inc (BM8) under the Base Case is hidden EUR. Compared with the current market price of 52.86 EUR, the stock appears hidden .

Intrinsic value calculated using DCF
Locked
Other reference points
Multiples estimate
Locked
Wall St target
€78.69

Do our valuations actually work? See backtest results .

BM8 Intrinsic Value
LOCKED
Unlock
Today vs. history

BM8 looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with BM8’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor BM8
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €52.86
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BM8

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
BioMarin Pharmaceutical Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

BMRN Insider Trading
Buy and sell transactions by insiders

Continue BM8 Research

Summary
BM8 intrinsic value, competitors valuation, and company profile.
DCF Valuation
BM8 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BM8 stock valuation using valuation multiples.
Wall St Estimates
BM8 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BM8 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other BioMarin Pharmaceutical Inc listings:
NASDAQ • USD
BMRN
 F • EUR
BM8
 XMUN • EUR
BM8
 LSE • USD
0HNC
Discover More
What is the Intrinsic Value of one BM8 stock?

The intrinsic value for BioMarin Pharmaceutical Inc (BM8) under the Base Case is hidden EUR.

Is BM8 stock undervalued or overvalued?

Compared with the current market price of 52.86 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 359,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.